Skip to main content

RE-SAMPLE

Objective

Multi-morbid complex chronic conditions (CCCs) are highly prevalent in patients with Chronic Obstructive Pulmonary Disease (COPD). As they have common risk factors and overlapping symptoms, this easily leads to delay of appropriate treatment. Timely and preventive care is essential, as exacerbations of COPD and CCCs are detrimental to patient, health and social outcomes. RE-SAMPLE will take a giant leap in the field of CCC disease management building upon and going beyond existing initiatives, towards evidence-based, inclusive, preventive care and targeted treatment, enabling to “treat a person, not the disease(s)”. RE-SAMPLE will create a knowledge base of multimodal data from health records, clinical studies, expert and patient knowledge and guidelines, and extend this with state-of-the-art Real World Data collection. Predictive modelling through privacy-preserving Artificial Intelligence (AI), will increase the understanding of CCCs including the interdependence of multi-morbidities, and evidence in effective interventions for CCC disease management. The inclusive design and citizen science approach, provides us with credible and accepted RWD tools and a patient-centred eHealth “companionship programme”. GDPR-compliance is carefully integrated from the beginning, and our platform allows for a strong advancement in secure algorithms using multi-party computation. Our AI approach enables statistical validation following clinical standards and useful explanations to build up clinical evidence and trust by the users. As such RE-SAMPLE will act upon the need for diversified, personalized care to alleviate the overall societal and economic burden of these CCCs. The RE-SAMPLE project significantly impact towards this direction not only through the development of the platform and companionship programme, but also through its implementation throughout Europe, enabling and guiding healthcare organizations its uptake in the privacy-sensitive domain of healthcare.

Call for proposal

H2020-SC1-2020-Single-Stage-RTD
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

UNIVERSITEIT TWENTE
Address
Drienerlolaan 5
7522 NB Enschede
Netherlands
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 1 159 390

Participants (9)

STICHTING MEDISCH SPECTRUM TWENTE
Netherlands
EU contribution
€ 621 712,50
Address
Haaksbergerstraat 55
7513 ER Enschede
Activity type
Other
KENTRO EREVNON PANEPISTIMIOU PEIRAIOS
Greece
EU contribution
€ 342 000
Address
Al. Papanastasiou 91
185 33 Peiraias
Activity type
Higher or Secondary Education Establishments
SIHTASUTUS TARTU ULIKOOLI KLIINIKUM
Estonia
EU contribution
€ 349 987,50
Address
Puusepa 1A
50406 Tartu
Activity type
Research Organisations
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS
Italy
EU contribution
€ 690 625
Address
Largo Francesco Vito 1
00168 Roma
Activity type
Research Organisations
FEDERATION EUROPEENNE DES HOPITAUX ET DES SOINS DE SANTE
Belgium
EU contribution
€ 278 530
Address
Avenue Marnix 30/17
1000 Bruxelles
Activity type
Other
DEUTSCHES FORSCHUNGSZENTRUM FUR KUNSTLICHE INTELLIGENZ GMBH
Germany
EU contribution
€ 903 585
Address
Trippstadter Strasse 122
67663 Kaiserslautern
Activity type
Research Organisations
ATOS IT SOLUTIONS AND SERVICES IBERIA SL
Spain
EU contribution
€ 455 625
Address
Ronda De Europa 5
28760 Tres Cantos Madrid
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ROESSINGH RESEARCH AND DEVELOPMENT BV
Netherlands
EU contribution
€ 601 590
Address
Roessinghsbleekweg 33
7522 AH Enschede
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
INNOVATION SPRINT
Belgium
EU contribution
€ 557 750
Address
Rue Clos Chapelle-aux-champs 30 Bte 1.3.30
1200 Bruxelles
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)